Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cunningham

Showing results (1441-1450 of 1,517) with videos related to

Pageof 152
Sort By:
Genome Biology|June 24, 2008
Gene expression response in target organ and whole blood varies as a function of target organ injury phenotypeEdward K Lobenhofer, J Todd Auman, Pamela E Blackshear, et al.
Molecular Oncology|September 7, 2025
PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration-resistant prostate cancerMoriah L Cunningham, Jasibel Vasquez-Gonzalez, Samantha M Barnada, et al.
Plos Genetics|September 21, 2011
Heterozygous mutations of FREM1 are associated with an increased risk of isolated metopic craniosynostosis in humans and miceLisenka E L M Vissers, Timothy C Cox, A Murat Maga, et al.
The Journal of Infectious Diseases|March 13, 2018
Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or OlderAnthony L Cunningham, Thomas C Heineman, Himal Lal, et al.
Open Forum Infectious Diseases|June 5, 2026
Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5-6 Years After Primary Vaccination in Adults ≥50 YearsRafael Leon, Javier Diez-Domingo, Charles Andrews, et al.
Cell Reports|September 21, 2022
An in situ analysis pipeline for initial host-pathogen interactions reveals signatures of human colorectal HIV transmissionHeeva Baharlou, Nicolas Canete, Erica E Vine, et al.
Human Vaccines & Immunotherapeutics|June 20, 2019
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trialsLidia Oostvogels, Thomas C Heineman, Robert W Johnson, et al.
Ebiomedicine|November 29, 2024
Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variantsLok Bahadur Shrestha, Katie Tungatt, Anupriya Aggarwal, et al.
Developmental Biology|April 5, 2011
The FaceBase Consortium: a comprehensive program to facilitate craniofacial researchHarry Hochheiser, Bruce J Aronow, Kristin Artinger, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 13, 2021
Accuracy and Reliability of 4D-CT and Flexible Laryngoscopy in Upper Airway Evaluation in Robin SequenceAustin S Lam, Michael D Bindschadler, Kelly N Evans, et al.
Pageof 152

Showing results (1441-1450 of 1,517) with videos related to

Sort By:
Pageof 152
Genome Biology|June 24, 2008
Gene expression response in target organ and whole blood varies as a function of target organ injury phenotypeEdward K Lobenhofer, J Todd Auman, Pamela E Blackshear, et al.
Molecular Oncology|September 7, 2025
PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration-resistant prostate cancerMoriah L Cunningham, Jasibel Vasquez-Gonzalez, Samantha M Barnada, et al.
Plos Genetics|September 21, 2011
Heterozygous mutations of FREM1 are associated with an increased risk of isolated metopic craniosynostosis in humans and miceLisenka E L M Vissers, Timothy C Cox, A Murat Maga, et al.
The Journal of Infectious Diseases|March 13, 2018
Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or OlderAnthony L Cunningham, Thomas C Heineman, Himal Lal, et al.
Open Forum Infectious Diseases|June 5, 2026
Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5-6 Years After Primary Vaccination in Adults ≥50 YearsRafael Leon, Javier Diez-Domingo, Charles Andrews, et al.
Cell Reports|September 21, 2022
An in situ analysis pipeline for initial host-pathogen interactions reveals signatures of human colorectal HIV transmissionHeeva Baharlou, Nicolas Canete, Erica E Vine, et al.
Human Vaccines & Immunotherapeutics|June 20, 2019
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trialsLidia Oostvogels, Thomas C Heineman, Robert W Johnson, et al.
Ebiomedicine|November 29, 2024
Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variantsLok Bahadur Shrestha, Katie Tungatt, Anupriya Aggarwal, et al.
Developmental Biology|April 5, 2011
The FaceBase Consortium: a comprehensive program to facilitate craniofacial researchHarry Hochheiser, Bruce J Aronow, Kristin Artinger, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 13, 2021
Accuracy and Reliability of 4D-CT and Flexible Laryngoscopy in Upper Airway Evaluation in Robin SequenceAustin S Lam, Michael D Bindschadler, Kelly N Evans, et al.
Pageof 152